What is the net vascular effect of dobutamine due to its receptor activity?

What is the net vascular effect of dobutamine due to its receptor activity?

• A. Vasoconstriction
• B. Vasodilation
• C. No change in vascular tone
• D. Variable depending on dose

Answer: (B)

Dobutamine mainly drives beta-1 adrenergic effects to boost cardiac contractility, but it also has mild beta-2 activity and negligible alpha-1 activity. Activation of vascular beta-2 receptors relaxes smooth muscle, producing vasodilation and a drop in systemic vascular resistance. Since alpha-1–mediated vasoconstriction is not a significant factor with dobutamine, the overall effect on the vasculature is vasodilation. This reduction in afterload occurs even as cardiac output increases, which is why dobutamine is favored when improving perfusion without raising vascular tone too much.

Dobutamine mainly drives beta-1 adrenergic effects to boost cardiac contractility, but it also has mild beta-2 activity and negligible alpha-1 activity. Activation of vascular beta-2 receptors relaxes smooth muscle, producing vasodilation and a drop in systemic vascular resistance. Since alpha-1–mediated vasoconstriction is not a significant factor with dobutamine, the overall effect on the vasculature is vasodilation. This reduction in afterload occurs even as cardiac output increases, which is why dobutamine is favored when improving perfusion without raising vascular tone too much.